23 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
changes to the health care system that could impact our ability to sell our products profitably. In particular, in 2010, the Patient Protection … and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (ACA) was enacted, which, among other things, subjected biologic
8-K
EX-1.1
ABSI
Absci Corp
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
operates its business in compliance with all applicable Health Care Laws (as defined below) and any other applicable requirements of the U.S. Food and Drug … or Regulatory Authority alleging or asserting material non-compliance with (A) any applicable Health Care Laws or (B) or any licenses, certificates, approvals
ARS
2022 FY
ABSI
Absci Corp
28 Apr 23
Annual report to shareholders
12:00am
a number of legislative and regulatory changes to the health care system that could impact our ability to sell our products profitably. In particular … , in 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (ACA) was enacted, which
10-K
e6ftpzbgq4dc6v 7rl66
22 Mar 22
Annual report
5:20pm
10-Q
djihnyt
7 Sep 21
Quarterly report
8:48am
424B4
1tkc mj79
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
EX-2.1
mgon3on3 vlgzzq4sxsk
8 Jul 21
IPO registration (amended)
5:04pm
S-1/A
i7rh33 m1
8 Jul 21
IPO registration (amended)
5:04pm
S-1
EX-10.12
bx7o37m3fllr3ox3c
30 Jun 21
IPO registration
3:20pm
S-1
dj11se7xlf9x ybu
30 Jun 21
IPO registration
3:20pm
DRS/A
lobdtor
16 Jun 21
Draft registration statement (amended)
12:00am
DRS
4wf0e3uqww0zt3ph0ly
6 May 21
Draft registration statement
12:00am
D
wpom8li
30 Mar 21
$125M in debt / options, sold $125M, 24 investors
4:58pm
D/A
4l2m6aqbhal
30 Mar 21
$70M in equity, sold $70M, 14 investors
12:00am
D/A
bdm igdl6fczi
26 Feb 21
$70M in equity, sold $70M, 14 investors
2:52pm